These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16902956)
21. Toward a stochastic formulation of microbial growth in relation to bioreactor performances: case study of an E. coli fed-batch process. Delvigne F; Destain J; Thonart P Biotechnol Prog; 2006; 22(4):1114-24. PubMed ID: 16889388 [TBL] [Abstract][Full Text] [Related]
22. Use of fed-batch cultivation for achieving high cell densities for the pilot-scale production of a recombinant protein (phenylalanine dehydrogenase) in Escherichia coli. Faulkner E; Barrett M; Okor S; Kieran P; Casey E; Paradisi F; Engel P; Glennon B Biotechnol Prog; 2006; 22(3):889-97. PubMed ID: 16739976 [TBL] [Abstract][Full Text] [Related]
23. [Hepatitis E virus capsid protein production by high cell density culture of recombinant Escherichia coli]. Liu RS; He ZQ; Li SW; Yang KY; Xian YL; Pang SQ; Zhang J; Li YM; Xia NS Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):450-5. PubMed ID: 15971623 [TBL] [Abstract][Full Text] [Related]
24. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli. Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443 [TBL] [Abstract][Full Text] [Related]
25. Production and characterization of recombinant dengue virus type 4 envelope domain III protein. Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971 [TBL] [Abstract][Full Text] [Related]
26. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli. Panda AK Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093 [TBL] [Abstract][Full Text] [Related]
27. Studies related to antibody fragment (Fab) production in Escherichia coli W3110 fed-batch fermentation processes using multiparameter flow cytometry. Want A; Thomas OR; Kara B; Liddell J; Hewitt CJ Cytometry A; 2009 Feb; 75(2):148-54. PubMed ID: 19051239 [TBL] [Abstract][Full Text] [Related]
28. Green fluorescent protein (GFP) leakage from microbial biosensors provides useful information for the evaluation of the scale-down effect. Delvigne F; Brognaux A; Francis F; Twizere JC; Gorret N; Sorensen SJ; Thonart P Biotechnol J; 2011 Aug; 6(8):968-78. PubMed ID: 21695786 [TBL] [Abstract][Full Text] [Related]
29. Design of growth-dependent biosensors based on destabilized GFP for the detection of physiological behavior of Escherichia coli in heterogeneous bioreactors. Han S; Delvigne F; Brognaux A; Charbon GE; Sørensen SJ Biotechnol Prog; 2013; 29(2):553-63. PubMed ID: 23335499 [TBL] [Abstract][Full Text] [Related]
30. Induction studies with Escherichia coli expressing recombinant interleukin-13 using multi-parameter flow cytometry. Shitu JO; Woodley JM; Wnek R; Chartrain M; Hewitt CJ Biotechnol Lett; 2009 Apr; 31(4):577-84. PubMed ID: 19125223 [TBL] [Abstract][Full Text] [Related]
31. A systematic approach for scale-down model development and characterization of commercial cell culture processes. Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951 [TBL] [Abstract][Full Text] [Related]
32. A two-compartment bioreactor system made of commercial parts for bioprocess scale-down studies: impact of oscillations on Bacillus subtilis fed-batch cultivations. Junne S; Klingner A; Kabisch J; Schweder T; Neubauer P Biotechnol J; 2011 Aug; 6(8):1009-17. PubMed ID: 21751400 [TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of enantiopure (S)-3-hydroxybutyric acid in metabolically engineered Escherichia coli. Lee SH; Park SJ; Lee SY; Hong SH Appl Microbiol Biotechnol; 2008 Jun; 79(4):633-41. PubMed ID: 18461320 [TBL] [Abstract][Full Text] [Related]
34. Characterization of the T7 promoter system for expressing penicillin acylase in Escherichia coli. Xu Y; Rosenkranz S; Weng CL; Scharer JM; Moo-Young M; Chou CP Appl Microbiol Biotechnol; 2006 Sep; 72(3):529-36. PubMed ID: 16411086 [TBL] [Abstract][Full Text] [Related]
35. Influence of bioreactor scale and complex medium on probing control of glucose feeding in cultivations of recombinant strains of Escherichia coli. Velut S; Castan A; Short KA; Axelsson JP; Hagander P; Zditosky BA; Rysenga CW; de Maré L; Haglund J Biotechnol Bioeng; 2007 Jul; 97(4):816-24. PubMed ID: 17163511 [TBL] [Abstract][Full Text] [Related]
36. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli. Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889 [TBL] [Abstract][Full Text] [Related]
37. [Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli]. Chang GD; Li ZL; Qin JY; Ma CQ; Luo YZ; Xu P Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):662-6. PubMed ID: 16176112 [TBL] [Abstract][Full Text] [Related]
38. Sensor combination and chemometric modelling for improved process monitoring in recombinant E. coli fed-batch cultivations. Clementschitsch F; Jürgen K; Florentina P; Karl B J Biotechnol; 2005 Nov; 120(2):183-96. PubMed ID: 16139381 [TBL] [Abstract][Full Text] [Related]
39. Scale-up of Escherichia coli growth and recombinant protein expression conditions from microwell to laboratory and pilot scale based on matched k(L)a. Islam RS; Tisi D; Levy MS; Lye GJ Biotechnol Bioeng; 2008 Apr; 99(5):1128-39. PubMed ID: 17969169 [TBL] [Abstract][Full Text] [Related]
40. Enhancement of over expression and chaperone assisted yield of folded recombinant aconitase in Escherichia coli in bioreactor cultures. Gupta P; Ghosalkar A; Mishra S; Chaudhuri TK J Biosci Bioeng; 2009 Feb; 107(2):102-7. PubMed ID: 19217544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]